Venture Life Group (LON:VLG) Shares Pass Below Fifty Day Moving Average - Here's What Happened

Key Points

• Venture Life Group shares have fallen below their 50-day moving average of GBX 58.30 to trade at GBX 53.01 ($0.71) as of the latest session.
• The company reported earnings of GBX 0.83 per share for the last quarter, with analysts forecasting a total of approximately 6.14 EPS for the current year.
• Insider Mark Adams purchased 88,999 shares at an average price of GBX 56, indicating confidence in the company as insiders currently own 6.77% of the stock.

Venture Life Group plc (LON:VLG - Get Free Report) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 58.30 ($0.78) and traded as low as GBX 53 ($0.71). Venture Life Group shares last traded at GBX 53.01 ($0.71), with a volume of 1,290,283 shares traded.

Venture Life Group Price Performance

The company has a current ratio of 2.22, a quick ratio of 1.48 and a debt-to-equity ratio of 28.45. The firm has a market cap of £68.51 million, a price-to-earnings ratio of -7,039.47, a PEG ratio of 5.67 and a beta of 0.30. The firm's 50 day simple moving average is GBX 58.30 and its two-hundred day simple moving average is GBX 52.02.

Venture Life Group (LON:VLG - Get Free Report) last issued its quarterly earnings results on Tuesday, September 30th. The company reported GBX 0.83 earnings per share (EPS) for the quarter. Venture Life Group had a return on equity of 0.99% and a net margin of 1.44%. On average, equities analysts forecast that Venture Life Group plc will post 6.1391542 EPS for the current year.

Insider Buying and Selling

In related news, insider Mark Adams purchased 88,999 shares of the company's stock in a transaction that occurred on Friday, October 3rd. The stock was acquired at an average price of GBX 56 per share, with a total value of £49,839.44. 6.77% of the stock is currently owned by company insiders.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.